Research records indexed for ACE-031

This page carries 11 of the 12 records that the literature query returned for ACE-031, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 1 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is ACE-031.

Indexed records

Records retrieved for ACE-031, newest first
RecordYearStudy typeModeln as statedWhat it reported
ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus) pmid:416868402026research-articleotherNot statedIndexed as research-article. study model from MeSH "Animals" with no rodent species heading. subject headings: Muscle, Skeletal; Callithrix; Activin Receptors, Type II; Recombinant Fusion Proteins; Body Composition.
Gel Electrophoretic Detection of Black Market ACE-031 pmid:403129242025research-articlerodentNot statedIndexed as research-article. study model from MeSH "Rats". subject headings: Activin Receptors, Type II; Recombinant Fusion Proteins; Blotting, Western; Electrophoresis, Polyacrylamide Gel; Immunoglobulin Fc Fragments.
The relationship between myodural bridge, atrophy and hyperplasia of the suboccipital musculature, and cerebrospinal fluid dynamics pmid:379193452023Research Support, Non-U.S. Gov't, research-articlerodentNot statedIndexed as research support, non-u.s. gov't, research-article. compound named in the abstract, not the title. study model from MeSH "Rats". subject headings: Neck Muscles; Dura Mater; Cerebrospinal Fluid; Mammals; Atrophy.
The relationship between myodural bridges, hyperplasia of the suboccipital musculature, and intracranial pressure pmid:360540962022Research Support, Non-U.S. Gov't, research-articlerodentNot statedIndexed as research support, non-u.s. gov't, research-article. compound named in the abstract, not the title. study model from MeSH "Rats". subject headings: Neck; Neck Muscles; Dura Mater; Mammals; Hyperplasia.
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial pmid:274628042017Randomized Controlled Trialhuman trialNot statedIndexed as randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Muscular Dystrophy, Duchenne; Activin Receptors, Type II; Walking; Drug Administration Schedule; Cohort Studies.
Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs pmid:268425852016Research Support, Non-U.S. Gov'totherNot statedIndexed as research support, non-u.s. gov't. compound named in the abstract, not the title. study model from MeSH "Animals" with no rodent species heading. subject headings: Muscle, Skeletal; Substance Abuse Detection; Doping In Sports; Dietary Supplements; Mass Spectrometry.
A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers pmid:231696072013Clinical Trial, Phase I, Randomized Controlled Trialhuman trialNot statedIndexed as clinical trial, phase i, randomized controlled trial. study model from MeSH "Humans" with publication type "clinical trial, phase i". subject headings: Adipose Tissue; Follicle Stimulating Hormone; Activin Receptors, Type II; Pharmaceutical Solutions; Magnetic Resonance Imaging.
[Anti-myostatin antibody therapy for myopathies] pmid:222775182011Journal ArticlerodentNot statedIndexed as journal article. compound named in the abstract, not the title. study model from MeSH "Mice". subject headings: Muscular Dystrophies; Antibodies; Myostatin.
[Myostatin blockade therapy for muscular atrophy] pmid:220684802011English AbstractrodentNot statedIndexed as english abstract. compound named in the abstract, not the title. study model from MeSH "Mice". subject headings: Muscular Atrophy; Activin Receptors, Type II; RNA, Small Interfering; Signal Transduction; Protein Structure, Tertiary.
Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type pmid:204668012010research-articlerodentNot statedIndexed as research-article. compound named in the abstract, not the title. study model from MeSH "Mice, Inbred C57bl". subject headings: Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Mice, Inbred C57BL; Hypertrophy.
Gateways to clinical trials pmid:203833462010BibliographyotherNot statedIndexed as bibliography. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Clinical Trials As Topic.

Where this page sits

Compound page: ACE-031. Class: Growth factors and growth hormone-derived compounds.

Retrieved 2026-10-12.

Sources

  1. Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:ace-031
  2. A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle & nerve (2013). pmid:23169607
  3. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial. Muscle & nerve (2017). pmid:27462804
  4. ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus). PloS one (2026). pmid:41686840
  5. Gel Electrophoretic Detection of Black Market ACE-031. Drug testing and analysis (2025). pmid:40312924

On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.

Related resources